Funding
← Back to your selection

Innovestor Life Science Fund

Activity from announced rounds

All recorded activity
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$34.1M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Biotech1

By country

Finland1

Rounds

1 in all activity
Kasvu Therapeutics

Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.

€30MSeries A
Participant